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Abstract
Background: Glial cell line-derived neurotrophic factor (GDNF) is a potent survival factor for many cell types, and
its expression is widespread both within and outside of the nervous system. The regulation of GDNF expression
has been extensively investigated but is not fully understood.
Results: Using a luciferase reporter assay, we identified the role of the 3’-untranslated region (3’-UTR) of the mouse
GDNF gene in the regulation of gene expression. We focused on a well-conserved A- and T-rich region
(approximately 200 bp in length), which is located approximately 1000 bp downstream of the stop codon in exon
4 of the gene and contains three typical AU-rich elements (AREs), AUUUA. Interestingly, these AREs are well
conserved in several GDNF genes. By testing reporter constructs containing various regions and lengths of the 3’-
UTR fused to the end of the luciferase gene, we demonstrated that the ARE-induced decrease in luciferase activity
correlates with the attenuation of the mRNA stability. Furthermore, we found that several regions around the AREs
in the 3’-UTR suppressed the luciferase activity. Moreover, the expression level of the GDNF protein was negligible
in C6 glioma cells transfected with the ARE-containing GDNF expression vector.
Conclusions: Our study is the first characterization of the possible role of AREs and other suppressive regions in
the 3’-UTR in regulating the amounts of GDNF mRNA in C6 cells.
Background
Glial cell line-derived neurotrophic factor (GDNF) was
originally purified from rat B-49-conditioned medium
and was characterized as a potent neurotrophic factor
for culturing dopaminergic neurons from the developing
substantia nigra [1]. GDNF is a distantly related member
of the transforming growth factor-b (TGF-b)s u p e r f a m -
ily [2], and additional GDNF homologs have also been
cloned [3-5]. GDNF expression is widespread in both
the central and peripheral nervous systems, in addition
to outside of the nervous system [6-9]. The targeted dis-
ruption of the mouse GDNF gene showed that GDNF
plays a critical role in the development of both kidney
and enteric neurons during embryogenesis [10,11].
GDNF possesses multifunctional properties that regulate
the development and differentiation of a variety of cell
lineages and acts as a neurotrophic factor for specific
types of neurons in the nervous system. Accordingly,
many investigators have reported the regulation of
GDNF mRNA in various types of cells, such as astro-
cytes, microglial cells and macrophages, both in vitro
and in vivo during tissue development and in pathophy-
siological states, including in response to inflammatory
stimuli, ischemic/hypoxic insults and spinal cord injury
[12-16]. However, the precise mechanisms regulating
GDNF mRNA expression are not yet fully understood.
For many genes, the promoter and enhancer activities
of their 5’-flanking regions and introns have been exten-
sively characterized in the evaluation of gene expression
regulation. However, the regulation of mRNA stability
has also been demonstrated to play an important role in
controlling gene expression [17]. In particular, a
sequence rich in adenosine (A) and uridine (U), contain-
ing the AU-rich element (ARE), AUUUA, has been
identified to regulate expression levels of mRNA. The
ARE motif was first identified within the 3’-untranslated
regions (3’-UTRs) of mRNAs encoding cytokines [18],
and many genes have been predicted to produce ARE-
containing mRNAs [19,20].
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AREs in the 3’-UTR of exon 4 in the mouse GDNF
gene. In addition, the ARE-containing region of GDNF
exon 4 fused to the end of the luciferase or the mouse
GDNF coding region markedly diminished each
expression.
Results
To evaluate the characteristic features of the 3’-UTR of
the mouse GDNF gene, which consists of an approxi-
mately 2800-bp long nucleotide sequence immediately
following the stop codon (Figure 1A), we first compared
the GDNF 3’-UTR among the following 11 species:
Danio rerio, Gallus gallus, Mus musculus, Rattus norve-
gicus, Canis lupus familiaris, Equus caballus, Bos taurus,
Sus scrofa, Macaca mulatta, Pan troglodytes and Homo
sapiens. Except for the nucleotide sequences of the
putative D. rerio and G. gallus GDNF 3’-UTRs, the
sequences in the proximal half (approximately 1200 bp)
and the end region (approxiately 200 bp) of the 3’-UTR
are homologous to each other. Interestingly, an A/T-
rich sequence, ATTTA [20], is well conserved among 11
species, and is serially located approximately 900 bp
downstream of the stop codon in the GDNF 3’-UTR
with the exception of D. rerio.A ss h o w ni nF i g u r e1 B ,
the homology of the nucleotide sequences of these A/T
rich regions between mouse and human is approxi-
mately 90%. Therefore, we characterized the features of
the well-conserved region of the mouse GDNF 3’-UTR,
particularly the ARE consensus sequences, in regulating
gene expression using a luciferase reporter system.
A ss h o w ni nF i g u r e2 ,w ei n s e r t e dt h ef u l l - l e n g t h
mouse GDNF 3’-UTR into downstream of the luciferase
gene in the pGL3-Promoter vector and estimated the
luciferase activity in transiently transfected C6 glioma
cells. The luciferase activity of the reporter gene con-
taining the full-length mouse GDNF 3’-UTR was mark-
edly lower than that of the control pGL3-Promoter
vector without the 3’-UTR (Figure 3A). A series of dele-
tion constructs of the 3’ end of the mouse GDNF 3’-
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Figure 1 Genomic structure of mouse GDNF. A) Partial schematic diagram of the mouse GDNF gene. The coding regions are indicated by
hatched boxes. In this study, the nucletotide immediatly after the stop codon in exon 4 is defined as +1. B) The nucleotide sequences of the A-
and T-rich region of the mouse and human GDNF 3’-UTR. Nucleotide sequences in the A- and T-rich region conserved between the mouse and
human GDNF 3’-UTR are indicated with asterisks.
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Figure 2 Schematic structure of the ARE-containing reporter constructs used in this study. Luciferase reporter constructs containing
various regions and lengths of the mouse GDNF 3’-UTR at the end of the luciferase coding region. The bold line represents a typical ARE
consensus sequence, AUUUA.
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Page 3 of 11UTR (Δ1, Δ4, Δ5a n dΔ7) revealed that the region
around the ARE sequences showed suppressive effects
on the expression of the reporter gene. In addition, the
unconserved region in the distal half of the mouse
GDNF 3’-UTR (Δ5) also suppressed luciferase activity.
We also observed a similar inhibitory effect of the 3’-
UTR (Δ2) on luciferase activity when the reporter con-
structs containing approximately 3.0 kb of the mouse
GDNF promoter region were included in the pGL3
Basic vector (Figure 3B and 3C). Furthermore, the
mouse GDNF construct that included the ARE
sequences following the coding region led to marginal
expression of the GDNF protein in transfected C6
glioma cells (Figure 4).
By studying the suppressive feature in the well-con-
served proximal half of the mouse GDNF 3’-UTR, we
found that the insertion of an approximately 300 bp
region of the 3’-UTR (+859/+1171) containing three
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Figure 3 The mouse GDNF 3’-UTR down-regulated luciferase activity in C6 cells. Thirty-six hours after transfection with the pGL3-Promoter
vector (pGL3pro) containing the indicated mouse GDNF 3’-UTR (A) or each mouse GDNF (mGDNF) promoter construct (B, C) containing the
indicated length of the 3’-UTR, the luciferase activity was measured as described in the Materials and Methods. Values represent the means ± SD
from 3 independent cultures, and the luciferase activity is expressed relative to that of the pGL3pro vector in panel A and to the pGL3-Basic
vector (pGL3b) in panel C.
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Figure 4 T h em o u s eG D N F3 ’-UTR attenuated the amount of
GDNF protein in C6 cells. A) Schematic structure of the mouse
GDNF coding construct containing the indicated length of the 3’-
UTR. B) Thirty-six hours after co-transfection with each mouse GDNF
construct and the pEGFP-N1 vector, the expression level of each
protein was detected using Western blot analyses as described in
the Materials and Methods.
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Page 4 of 11AREs (Δ8) into the pGL3-Promoter vector was sufficient
to suppress the luciferase activity in the C6 cells (Figure
5A). In contrast, the insertion of this suppressive region
in the opposite direction (Δ8R) and the 3’-UTR (+1/
+313) region of the same length (Δ7) into the pGL3-
Promoter vector had little effect on the luciferase activ-
ity in the C6 cells. The expression of luciferase mRNA
in the C6 cells transfected with the Δ8c o n s t r u c tw a s
negligible compared to the cells transfected with the Δ7
or Δ8R construct (Figure 5B), and deletion of the core
ARE region (+938/+1014) from the Wt, Δ2 and Δ8c o n -
structs partialy recovered the promoter activity (Figure
6). The luciferase activity of the Wt or Δ2c o n s t r u c ti n
transfected cells was extremely low (approximately 2%
of the pGL3pro-transfected cells), however the deletion
of the core ARE region from the Wt and Δ2 constructs
caused an approximately 2-fold increase in the promoter
activity. The luciferase activity in the Δ9c o n s t r u c t -
transfected cells was approximately half of that in the
pGL3pro-transfected cells and was almost equal to that
in the cells transfected with the Δ13 construct, which
contains the upstream sequence (+859/+932) from the
core ARE region only. Furthermore, we evaluated the
stability of the luciferase mRNA in each case using Acti-
nomycin D (Act-D) (Figure 7). To estimate the remain-
ing luciferase mRNA in each of the reporter-transfected
cell lines, we first determined the cycle count of the
polymerase chain reaction (PCR) to detect the luciferase
mRNA in the Δ8 construct-transfected cells. Three
hours after treatment with Act-D, the amount of lucifer-
ase mRNA in the C6 cells transfected with the Δ8c o n -
struct was approximately 25% lower than that in the
cells transfected with the original pGL3-Promoter vec-
tor; however, this difference was not significant.
Lastly, we characterized the AREs of the mouse GDNF
3’-UTR and the nucleotide sequences adjacent to these
elements by generating various deletion reporter con-
structs. The C6 cells transfected with the 3’-UTR con-
struct containing the sequences from either side of the
AREs (Δ10 and Δ15) showed lower luciferase activities;
however, the cells transfected with the 3’-UTR construct
without these adjacent sequences (Δ20) showed higher
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Figure 5 ARE in the mouse GDNF 3’-UTR down-regulated luciferase mRNA in C6 cells. A) Thirty-six hours after transfection with each
GDNF promoter construct containing the indicated length of the 3’-UTR, the luciferase activity was measured as described in the Materials and
Methods. Values represent the means ± SD from 3 independent cultures and are expressed relative to the luciferase activity of the pGL3-
Promoter vector (pGL3pro). Δ8R represents a reporter construct in which the Δ8 fragment of the mouse GDNF 3’-UTR was inserted in the
opposite direction. B) Thirty-six hours after transfection with the indicated reporter constructs, total RNA from each sample was extracted and
subjected to RT-PCR as described in the Materials and Methods. The relative mRNA level of luciferase was calculated by the comparison to b-
actin-normalized values of the mRNA level in pGL3-Promoter vector-transfected cells. Values represent the means ± SD from 3 independent
cultures and are expressed relative to the luciferase activity (A) and mRNA (B) of the pGL3-Promoter vector. *p < 0.01, compared to the luciferase
activity in the pGL3-Promoter vector-transfected cells (pGL3pro).
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Page 5 of 11luciferase activity than both the Δ10 and Δ15 constructs
(Figure 8). The C6 cells transfected with a construct of
the 3’-UTR serially deleted from either side of the Δ8
region showed higher luciferase activities when the
length of the Δ8 region was reduced and each ARE was
sequentially deleted (Figure 9). Consistent with the
results in Figure 6B, the Δ13 construct, which lacked
the core ARE and following downstream regions (+933/
+1171), still suppressed the lucifease activity by approxi-
mately 50%.
Discussion
Using a luciferase reporter assay, our results are the first
to demonstrate that the mouse GDNF 3’-UTR has mul-
tiple suppressive regions regulate gene expression. In
this study, we employed three types of promoters (SV40,
CMV and the intrinsic mouse GDNF promoter) and
two genes (luciferase and GDNF) to characterize the
features of the mouse GDNF 3’-UTR. Among several
regions in the mouse GDNF 3’-UTR, we focused on the
role of the AREs in the middle region of the 3’-UTR in
regulating gene expression in a post-transcriptional
manner, such as through mRNA stability, because these
particular AREs are higly conserved among eleven dif-
ferent organisms. In our experiments, the C6 cells trans-
fected with an expression construct in which the AU-
rich region was immediately downstream of the coding
region expressed negligible amounts of mRNA and pro-
tein. These results suggest that the suppressive effects of
this AU-rich region in the mouse GDNF 3’-UTR are not
affected by the coding sequences or promoters. Barreau
et al. have proposed that there are three different classes
of AREs [20], and according to their classification, the
AU-rich region in the GDNF 3’-UTR belongs to Class I
because it contains the ARE consensus sequences,
AUUUA. In our deletion analyses, the reporters in
which the AREs were serially deleted gradually lost their
suppressive properties, demonstrating that three ARE
consensus sequences in the mouse GDNF 3’-UTR play a
cooperative role in regulating the amounts of mRNA.
However, our results also indicated that this suppressive
function does not simply depend on these conserved
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Figure 6 Effect of the deletion of the core ARE on the luciferase activity in C6 cells. Thirty-six hours after transfection with the indicated
reporter constructs (A, B), the luciferase activity was measured as described in the Materials and Methods. Values represent the means ± SD
from more than 3 independent cultures and are expressed relative to the luciferase activity of the pGL3-Promoter vector. *p < 0.01, compared to
the luciferase activity in the Δ8 construct-transfected cells (Δ8).
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Page 6 of 11AREs. The Δ20 construct containing only the core ARE
region (+933/+1010) did not exhibit a convincing sup-
pressive effect. The Δ13 construct containing only the
short region (+859/+932), just upstream from the ARE
region, still exhibited reduced luciferase activity of
approximately 50% compared to pGL3pro. It seems that
both region adjacent to the AREs might be required to
suppress the luciferase activity effectively. Hajarnis et al.
have reported that the GC-rich sequences adjacent to an
ARE in the 3’-UTR of phosphoenolpyruvate carboxyki-
nase also function to destabilize the mRNA [21]. We
also demonstrated that the core ARE-deletion (+938/
+1014) from entire GDNF 3’-UTR caused an apparent
doubling of luciferase activity. It is possible that other
suppressive factors recognize currently uncharacterized
regions in the mosue GDNF 3’-UTR to exert the full
suppressive effect. In contrast to the high conservation
of the region around the AREs among 11 species, the
distal half of the mouse GDNF 3’-UTR (+1075/+2518) is
approximately 85% homologous to only the putative rat
GDNF 3’-UTR. Meanwhile, the posterior half of the
human GDNF 3’-UTR is highly similar to only the puta-
tive Rhesus and chimpanzee sequences. The homology
is lower between rodents and primates. As shown in
F i g u r e s2 ,3a n d6 ,t h i su n c o n s e r v e dr e g i o ns h o w e da
marked suppressive effect on the promoter activity, and
the deletion of the core ARE from the Wt and Δ2c o n -
structs recovered the activity to a lesser extent. There-
fore, we conclude that in addition to our characteirzed
AREs, common and species-specific negative factors
cooperatively recognize the concensus sequences in the
GDNF 3’-UTR to regulate the expression of the GDNF
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Figure 7 ARE in the mouse GDNF 3’-UTR destabilized luciferase mRNA in C6 cells. Thirty-six hours after transfection with the indicated
reporter construct, together with the pEGFP-N1 vector, the cells were harvested (0 h, untreated cells) or treated with Act-D (5 μg/ml) for 1 or 3
h. The total RNA isolated from each sample was subjected to RT-PCR, and the relative mRNA levels of luciferase and EGFP were calculated by a
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Page 7 of 11gene. However, the precise mechanism for the down-
regulation of expression by the 3’-UTR remain to be
determined.
It has been reported that an ARE in the 3’-UTR regu-
lates the expression of many types of genes, including
some cytokines, immediate early genes and trophic fac-
tors [18-20]. Moreover, many families of RNA-binding
proteins that specifically recognize an ARE in several
genes have been identified. AUF1 consists of four spli-
cing variants and is reported to destabilize mRNA
through an ARE [22,23]. In contrast, the ELAV family
members, including HuR, HuD, HuB and HuC, are sug-
gested to enhance mRNA stabilization [24-27]. We
transfected our reporter constructs containing the
mouse GDNF 3’-UTR together with the AUF1 splicing
variants or the ELAV family members; however, none of
the ARE-binding proteins restored luciferase activity in
the C6 cells transfected (unpublished data). Some sti-
muli (e.g., NGF [26], GM-CSF [27], PMA [28], LPS [29]
and heat shock [30]) have been reported to stabilize
mRNA through the activation of intracellular signaling
pathways [26-32] and/or the modification of RNA-
binding proteins [26]. We attempted to examine the
effects of PMA and LPS, which were previously reported
to up-regulate endogenous GDNF mRNA, but neither
stimulus inhibited the suppressive effect of an ARE in
the mouse GDNF 3’-UTR. As some factors, including
poly(A)-binding proteins [33] and microRNAs [34], have
also been reported to post-transcripionally regulate the
amount of mRNA with a 3’-UTR in quantity, we investi-
gated whether PABPc1, a poly(A)-binding protein,
affects the suppressive effect of the mouse GDNF 3’-
UTR. Our results show that PABPc1 overexpression
does not affect this suppressive feature. Therefore, it is
still unclear which factors (proteins and/or RNA mole-
cules) participate in GDNF expression via its 3’-UTR.
Using miRBase http://www.mirbase.org/ to search for
microRNAs that might recognize the ARE and non-ARE
regions, we found that some microRNAs (e.g., mmu-
miR-1955-5p and mmu-miR-883a-3p) are predictied to
associate with the suppressive regions within the Δ13
and Δ 5 regions, respectively. Thus, further studies on
the identification and characterization of negative regu-
lators that destabilize the GDNF mRNA in combination
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Figure 8 Role of AU rich regions adjacent to the three AREs in down-regulating luciferase activity in C6 cells. Thirty-six hours after
transfection with the indicated reporter constructs (A, B), the luciferase activity was measured as described in the Materials and Methods. Values
represent the means ± SD from more than 3 independent cultures and are expressed relative to the luciferase activity of the pGL3-Promoter
vector. *p < 0.01, compared to the luciferase activity in the Δ8 construct-transfected cells (Δ8).
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Page 8 of 11with AREs and other suppressive regions of the GDNF
3’-UTR are required to determine the mehanisms for
regulating GDNF expression under pathophysilological
conditions.
We previously characterized three distinct mouse
GDNF promoters upstream of exons 1, 2 and 3 [35,36].
Brodbeck et al. reported that Six2, a homeobox gene,
recognizes its consensus sequence in the mouse GDNF
promoter 1 and potentiates its promoter activity [37].
With the exception of Six2 as a regulator of renal devel-
opment [38], none of the transcriptional factors related
to neuronal inflammation have been identified, although
many inflammatory stimuli are reported to enhance
intrinsic GDNF mRNA expression in vivo and in vitro
[12-16].
Conclusion
Our present study is the first to suggest the possible role
of several regions in the 3’-UTR of the mouse GDNF
gene in regulating its gene expression. Among these
regions, we characterized the suppressive feature of a
well-conserved A- and T-rich region (approximately 200
bp in length) in the mouse GDNF 3’-UTR. Based on the
well-conserved nucleotide sequences surrounding the
AREs among 11 species, the ARE of the human GDNF
3’-UTR is predicted to have a similarly suppressive role.
Further characterization of the interaction of this ARE
with other suppressive regions in the GDNF 3’-UTR,
together with that of the GDNF promoter, will help to
clarify the complex regulatory mechanisms of GDNF
gene expression.
Methods
Construction of plasmids
For the preparation of the reporter constructs contain-
ing the 3’-UTR of mouse GDNF, various lengths of the
3’-UTR were amplified by PCR and cloned into the
pGL3-Promoter vector (pGL3pro) (Promega) at the Xba
I site that is immediately downstream of the luciferase
gene. In this study, the nucleotide immediately after the
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Figure 9 Effect of three ARE on luciferase activity in C6 cells. Thirty-six hours after transfection with the indicated reporter constructs (A, B),
the luciferase activity was measured as described in the Materials and Methods. Values represent the means ± SD from 3 independent cultures
and are expressed relative to the luciferase activity of the pGL3-Promoter vector. *p < 0.01, compared to the luciferase activity in the Δ8
construct-transfected cells (Δ8).
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defined as +1 (Figure 1A). The reporter constructs used
in this study are shown in Figure 2. The mouse GDNF
3’-UTR was also cloned into the pGL3-Basic vector con-
taining the mouse GDNF promoter 1 (GDNF pro) [35].
The coding region of mouse GDNF fused with the 3’-
UTR was amplified by PCR and then cloned into the
pcDNA3.1 vector [39].
Cell culture and treatment
C6 cells were maintained in Ham’sF - 1 0m e d i u m( I n v i -
trogen) supplemented with 3% fetal bovine serum and
7% horse serum. Transfection of each construct used in
this study was performed using the Lipofectamine-Plus
reagent (Invitrogen) according to the manufacturer’s
instructions [39].
Reporter gene assay
The reporter constructs and the pRL-TK vector, an
internal control, were transfected into C6 cells in a 48-
well plate. Thirty-six hours after transfection, the cells
were lysed, and the luciferase activity in each lysate was
measured using a Dual-Luciferase assay system (Pro-
mega). The reporter activity in each lysate was normal-
ized to the co-transfected Renilla luciferase activity, and
the results are shown as the relative luciferase activity.
Western blot analysis
The expression levels of GDNF and EGFP in the cell
lysates were estimated by Western blotting, as described
previously [39]. Briefly, the transfected cells were lysed
with SDS-Laemmli sample buffer [62.5 mM Tris-HCl
(pH 6.8), 2% SDS and 10% glycerol], and the protein
concentration of each cell lysate was determined using
the Protein DC assay kit (Bio-Rad). Equal amounts of
each sample were separated by 12.5% SDS-polyacryla-
mide electrophoresis gels, transferred onto polyvinyli-
dene difluoride membranes (GE Healthcare Bioscience)
and identified using a primary antibody against GDNF
(Santa Cruz Biotechnology) or EGFP (Roche Biochem-
icals) and enhanced chemiluminescence (GE Healthcare
Biosciences).
Analysis of mRNA stability
The cells were harvested thirty-six hours after co-trans-
fection with each reporter construct and an enhanced
green fluorescence protein (EGFP) expression vector
(pEGFP-N1) (Clontech) as an internal control. Act-D (5
μg/ml) was added to the cells 1 or 3 h before harvesting
the cells, which were lysed with Trizol to extract the
total RNA. The total RNA was treated with DNase
(NIPPON GENE) for 15 min according to the manufac-
turer’s instructions to degrade the contaminating
reporter constructs and estimate the amount of each
mRNA. After re-extraction of the treated RNA, the total
RNA (0.5 μg) was converted to cDNA by reverse tran-
scription using random ninemers to prime SuperScript
III reverse transcriptase (RT) (Invitrogen), as previously
described [15]. To estimate the expression level of each
mRNA by RT-PCR, the specific cDNAs were mixed and
amplified using PCR (Taq PCR kit, Takara). The RT-
PCR primers used in this study were as follows: the luci-
ferase sense primer, 5’-GGTGGCTCCCGCTGAATT-3’;
the luciferase antisense primer, 5’-
GATTTTTCTTGCGTCGAG-3’;t h eE G F Ps e n s ep r i -
mer, 5’-ACCTACGGCAAGCTGACCCTGAA-3’;t h e
EGFP antisense primer, 5’-CTCCAGCTTGTGCCC-
CAGGAT-3’;t h eb-actin sense primer, 5’-
TGTATGCCTCTGGTCGTACC-3’;a n dt h eb-actin
antisense primer, 5’-CCACGTCACACTTCATGATGG-
3’. By measuring the remaining RNA to estimate the
mRNA stability, we first determined the appropriate
number of cycles of amplification for each gene. For the
detection of luciferase, EGFP and b-actin mRNAs, the
number of cycles of amplification was 28, 25 and 21,
respectively. After the amplification of each gene, the
products were separated by electrophoresis on 2.0%
agarose gels and visualized using ethidium bromide. The
fluorescence intensity of each band was scanned and
quantified using NIH-Image software [15,16]. To evalu-
ate the lower amount of luciferase mRNA derived from
the pGL3-promoter vector containing the GDNF 3’UTR
region, additional cycles of amplification were performed
to produce fluorescence intensities in the Δ8-transfected
untreated cells (0 h) that were almost similar to those
derived from the pGL3pro-transfected cells. The experi-
ments were repeated to confirm the reproducibility.
Statistical analysis
The results are expressed as the mean ± SD of more
than three cultures. The statistical analysis was per-
formed using one way-ANOVA followed by Fischer’s
PLSD test. A probability of p < 0.01 was considered to
be statistically significant.
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